The ameliorating effect of withaferin A on high-fat diet-induced non-alcoholic fatty liver disease by acting as an LXR/FXR dual receptor activator

Introduction: Non-alcoholic fatty liver disease (NAFLD) incidence has been rapidly increasing, and it has emerged as one of the major diseases of the modern world. NAFLD constitutes a simple fatty liver to chronic non-alcoholic steatohepatitis (NASH), which often leads to liver fibrosis or cirrhosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiragannavar, Varsha D., Sannappa Gowda, Nirmala G., Puttahanumantharayappa, Lakshana D., Karunakara, Shreyas H., Bhat, Smitha, Prasad, Shashanka K., Kumar, Divya P., Santhekadur, Prasanna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995434/
https://www.ncbi.nlm.nih.gov/pubmed/36909161
http://dx.doi.org/10.3389/fphar.2023.1135952

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995434/
https://www.ncbi.nlm.nih.gov/pubmed/36909161
http://dx.doi.org/10.3389/fphar.2023.1135952

Ejemplares similares